Filter Results
:
(2,086)
Show Results For
-
All HBS Web
(2,086)
- People (8)
- News (579)
- Research (956)
- Events (3)
- Multimedia (25)
- Faculty Publications (564)
Show Results For
-
All HBS Web
(2,086)
- People (8)
- News (579)
- Research (956)
- Events (3)
- Multimedia (25)
- Faculty Publications (564)
- Web
Admissions & Financial Support - Doctoral
Yueran Ma Business Economics Erica Moszkowski Business Economics Sagar Saxena Business Economics Aurora Turek Organizational Behavior Ran Zhuo Business Economics A Jay Holmgren Health Policy (Management) Evan DeFilippis Organizational...
View Details
- March 2021 (Revised August 2021)
- Supplement
Wendell Weeks at Corning Inc. (B): Valor Glass and the COVID-19 Pandemic
By: Ryan Raffaelli and Aldo Sesia
The (B) case offers a detailed account of Wendell Weeks’s innovation strategy at Corning, and how his approach played a critical role in the COVID-19 pandemic. It illustrates the company’s philosophy of making long-term investments in promising new technologies and...
View Details
Keywords:
Innovation and Invention;
Innovation Strategy;
Technological Innovation;
Disruptive Innovation;
Information Technology;
Leadership;
Health Pandemics;
Technology Industry;
United States;
New York (city, NY)
Raffaelli, Ryan, and Aldo Sesia. "Wendell Weeks at Corning Inc. (B): Valor Glass and the COVID-19 Pandemic." Harvard Business School Supplement 421-078, March 2021. (Revised August 2021.)
- 02 Nov 2017
- News
Could a Hackathon Help Solve the Heroin Crisis?
- 2016
- Book
Innovation Policy and the Economy, Volume 17
By: Shane Greenstein, Josh Lerner and Scott Stern
The seventeenth volume of the National Bureau of Economic Research’s Innovation Policy and the Economy provides an accessible forum for bringing the work of leading academic researchers to an audience of policymakers and those interested in the interaction...
View Details
Greenstein, Shane, Josh Lerner and Scott Stern, eds. Innovation Policy and the Economy, Volume 17. Chicago: University of Chicago Press, 2016.
- August 1995 (Revised June 1997)
- Case
Hillcrest Research Associates, Inc.
Hillcrest designs and administers testing procedures for drugs to determine whether they pass FDA specifications. As the company grows, it encounters problems with information technology and with the clinical research associates, who feel pressured to report more...
View Details
Keywords:
Growth Management;
Information Technology;
Health Testing and Trials;
Pharmaceutical Industry
Barnes, Louis B. "Hillcrest Research Associates, Inc." Harvard Business School Case 496-021, August 1995. (Revised June 1997.)
- 2008
- Book
On Competition
By: M. E. Porter
Competition is one of society's most powerful forces for making things better in many fields of human endeavor. The study of competition and the creation of value, in their full richness, have preoccupied me for several decades. Competition is pervasive, whether it...
View Details
Porter, M. E. On Competition. Updated and Expanded Ed. Boston: Harvard Business School Publishing, 2008.
- Web
Faculty & Research
this paper shows that under a wide range of conditions, actors prefer to enact a less than fully informative experiment designed to persuade—even when a fully informative experiment is feasible at the same cost. Initiatives & Projects View Details
- Web
Employment Data
Products 4% Entertainment / Media 1% Health Care 5% Investment Banking 3% Investment Management / Hedge Fund 6% Manufacturing 6% Nonprofit / Government 5% Other Financial Services 3% Private Equity 17% Retail 1% Services 2% View Details
- October 2019 (Revised April 2020)
- Background Note
Note on Funding Deep Tech Startups
By: Karim Lakhani, Peter Barrett and Noubar Afeyan
This Background Note provides essential information on funding deep technologies—those technologies that were inherently capital intensive, time consuming, risky, and potentially disruptive. Both dilutive and non-dilutive sources of investment are highlighted, along...
View Details
Keywords:
Entrepreneurship;
Energy;
Venture Capital;
Corporate Finance;
Initial Public Offering;
Investment;
Health Testing and Trials;
Innovation and Invention;
Technological Innovation;
Intellectual Property;
Product Design;
Product Development;
Information Technology;
Research and Development;
Risk and Uncertainty;
Technology Industry;
Technology Industry;
United States;
North America;
Europe;
Asia
Lakhani, Karim, Peter Barrett, and Noubar Afeyan. "Note on Funding Deep Tech Startups." Harvard Business School Background Note 620-029, October 2019. (Revised April 2020.)
- August 2003 (Revised March 2004)
- Case
Wintel (A): Cooperation or Conflict
By: David B. Yoffie, Ramon Casadesus-Masanell and Sasha Mattu
Examines the dynamic relationship between two complementors: Intel and Microsoft. Set in 1995, the case asks how Intel and Microsoft should solve a serious division between the two companies that threatens the health of the PC industry.
View Details
Keywords:
Conflict Management;
Competition;
Cooperation;
Information Technology Industry;
Information Technology Industry;
Information Technology Industry
Yoffie, David B., Ramon Casadesus-Masanell, and Sasha Mattu. "Wintel (A): Cooperation or Conflict." Harvard Business School Case 704-419, August 2003. (Revised March 2004.)
- Web
MS/MBA Biotechnology: Life Sciences - MBA
works closely with the Greater Boston area, one of the largest biotech clusters in the world. Key organizations comprising the Harvard health and life science community include, the HBS Health Care...
View Details
- 24 Jan 2017
- First Look
First Look at New Research: January 24, 2017
Yoshimi Anzai, Marta E. Heilbrun, Derek Haas, Luca Boi, Kirk Moshre, Satoshi Minoshima, and Vivian S. Lee Abstract—The lack of understanding the true costs (not charges) of delivering health care services poses tremendous challenges in...
View Details
Keywords:
Sean Silverthorne
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While...
View Details
Keywords:
Public Sector;
Science-Based Business;
Research and Development;
Sovereign Finance;
Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- Web
FAQs - MBA
Boston’s biotech, research and entrepreneurial ecosystems? What resources did MS/MBA students have and are there opportunities outside the classroom? The MS/MBA Biotech program is part of a larger community of health care interested...
View Details
William A. Sahlman
William Sahlman is a Baker Foundation Professor of Business Administration at Harvard Business School.
Mr. Sahlman received an A.B. degree in Economics from Princeton University (1972), an M.B.A. from Harvard University (1975), and a Ph.D. in Business... View Details
Keywords:
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care;
health care
- Web
Faculty & Advisors - MBA
University; SB/SM, Massachusetts Institute of Technology Chris leads MPM Capital’s public market investing as portfolio manager for BioImpact Equities (formerly known as Burrage Capital) and the Oncology Impact Funds. Previously, Chris...
View Details
Derek C. M. van Bever
Derek van Bever is a Senior Lecturer in the General Management Unit of Harvard Business School. He teaches courses in both years of the MBA program (“Leadership and Corporate Accountability” in the first-year required curriculum and “Building and Sustaining a... View Details
- Web
Capstone - MBA
investigated potential genetic technologies like Tissue Regeneration Enhancer Elements (TREEs), which may enable the replacement of damaged or dead sound-sensing inner ear hair cells. Redefining Female Reproductive View Details
- 2013
- Case
Advanced Leadership Pathways: Laurent Adamowicz and Bon'App
By: Rosabeth M. Kanter, Juliane Calingo Schwetz and Patricia Bissett Higgins
After a successful career as Chairman and CEO of Paris-based luxury food company, Fauchon, Laurent Adamowicz, sought to reduce obesity and improve health outcomes. Adamowicz created a mobile application to provide consumers with more accessible and interpretable...
View Details
Keywords:
Nutritional Information;
Obesity;
Weight Loss;
App Development;
Business Startups;
Nutrition;
Health;
Information;
Mobile and Wireless Technology;
Entrepreneurship;
Social Enterprise;
Information Technology Industry;
Information Technology Industry
Kanter, Rosabeth M., Juliane Calingo Schwetz, and Patricia Bissett Higgins. "Advanced Leadership Pathways: Laurent Adamowicz and Bon'App." Harvard Business Publishing Case 314-028, 2013.
- 05 Aug 2020
- News